Compounds > 5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one
Page last updated: 2024-09-03

5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one and 4-butyrolactone

5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one has been researched along with 4-butyrolactone in 1 studies

Compound Research Comparison

Studies
(5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one)		Trials
(5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one)		Recent Studies (post-2010)
(5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one)		Studies
(4-butyrolactone)		Trials
(4-butyrolactone)		Recent Studies (post-2010) (4-butyrolactone)
11014,456781,823

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Evans, DL; Figur, LM; Huff, RM; Lahti, RA; Moon, MW1

Other Studies

1 other study(ies) available for 5-(dipropylamino)-5,6-dihydro-4h-imidazo-(5,1ij)quinolin-2(1h)-one and 4-butyrolactone

ArticleYear
Pre- and postsynaptic dopaminergic activities of U-86170F.
    Naunyn-Schmiedeberg's archives of pharmacology, 1991, Volume: 344, Issue:5

    Topics: 4-Butyrolactone; Administration, Oral; Aminoquinolines; Animals; Apomorphine; Dopamine Agents; Injections, Intraperitoneal; Male; Mice; Motor Activity; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Synapses

1991